Chronic myeloid leukemia, BCR/ABL-positive, in remission

Clinical trials for Chronic myeloid leukemia, BCR/ABL-positive, in remission explained in plain language.

Never miss a new study

Get alerted when new Chronic myeloid leukemia, BCR/ABL-positive, in remission trials appear

Sign up with your email to follow new studies for Chronic myeloid leukemia, BCR/ABL-positive, in remission, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Leukemia drug holiday: study tests if patients can pause treatment

Disease control Ongoing

This study looks at whether people with chronic myeloid leukemia (CML) who have had a stable, deep response to treatment for at least two years can safely stop taking their daily targeted therapy (TKI). It involves 17 adults who have been on TKI for over three years. The main goa…

Matched conditions: CHRONIC MYELOID LEUKEMIA, BCR/ABL-POSITIVE, IN REMISSION

Phase 2 • Sponsor: Baylor College of Medicine • Aim: Disease control

Last updated Jun 27, 2026 12:28 UTC

Chronic myeloid leukemia, BCR/ABL-positive, in remission

Get alerted when new Chronic myeloid leukemia, BCR/ABL-positive, in remission trials appear

Leukemia drug holiday: study tests if patients can pause treatment